v3.26.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jul. 31, 2026
Jul. 25, 2025
Apr. 24, 2026
Apr. 25, 2025
Apr. 26, 2024
Income Statement [Abstract]          
Net sales $ 843 $ 723 $ 3,102 $ 2,715 $ 2,469
Cost of products sold 378 314 1,422 1,187 1,032
Gross profit 465 409 1,680 1,528 1,436
Operating expenses:          
Research and development expense 115 125 448 436 437
Selling, general, and administrative expense 312 283 1,183 1,080 1,057
Certain litigation charges, net (2) 17 18 165 0
Other operating expense (income), net 36 (2) 221 (8) 11
Operating loss 5 (13) (190) (146) (69)
Other non-operating expense (income), net 0 0 (1) 1 1
Loss before income taxes 4 (13) (189) (147) (70)
Income tax provision 4 3 128 52 38
Net loss 0 (16) (317) (198) (107)
Net income attributable to noncontrolling interests 0 (3) (16) (15) (5)
Net loss attributable to the Company $ 0 $ (19) $ (333) $ (213) $ (112)
Earnings (loss) per share:          
Earnings (loss) per share, basic (usd per share) $ 0.00 $ (0.08) $ (1.30) $ (0.84) $ (0.44)
Earnings (loss) per share, diluted (usd per share) $ 0.00 $ (0.08) $ (1.30) $ (0.84) $ (0.44)
Weighted-average shares outstanding          
Basic weighted average shares outstanding (shares) 281,000,000.0 252,800,000 256,600,000 252,800,000 252,800,000
Diluted weighted average shares outstanding (shares) 281,000,000.0 252,800,000 256,600,000 252,800,000 252,800,000